Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Should You Buy?

Eurofins Scient (OTCMKTS:ERFSF) gapped up before the market opened on Tuesday . The stock had previously closed at $74.9060, but opened at $79.78. Eurofins Scient shares last traded at $79.78, with a volume of 76 shares.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ERFSF. Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold”.

Eurofins Scient Trading Up 0.7%

The company has a 50 day moving average of $77.92 and a 200-day moving average of $74.84. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.